Eli Lilly ready to ship 100,000 doses of Covid drug; waiting for FDA nod

The US government agreed to pay Eli Lilly & Co $375 million for 300,000 vials of its experimental Covid-19 antibody as it undergoes regulatory review for emergency-use authorisation.
 

The funding from Operation Warp Speed, the White House-led effort to quickly secure Covid-19 vaccines and therapeutics, hinges on Lilly’s antibody therapy receiving a green light from the US Food and Drug Administration (FDA). The initial agreement is for delivery over the first two months following an emergency authorisation. The US has the option to purchase an additional 650,000 vials through next June for as much as $812.5 million, according to a